These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10223958)

  • 1. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs.
    Akova M; Gür D; Livermore DM; Kocagöz T; Akalin HE
    Antimicrob Agents Chemother; 1999 May; 43(5):1298-300. PubMed ID: 10223958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro efficacy of several antimicrobial combinations against Brucella canis and Brucella melitensis strains isolated from dogs.
    Mateu-de-Antonio EM; Martín M
    Vet Microbiol; 1995 Jun; 45(1):1-10. PubMed ID: 7653024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice.
    Domingo S; Gastearena I; Vitas AI; López-Goñi I; Dios-Viéitez C; Díaz R; Gamazo C
    J Antimicrob Chemother; 1995 Oct; 36(4):647-56. PubMed ID: 8591939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
    Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
    Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of
    Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
    Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
    Maves RC; Castillo R; Guillen A; Espinosa B; Meza R; Espinoza N; Núñez G; Sánchez L; Chacaltana J; Cepeda D; González S; Hall ER
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1279-81. PubMed ID: 21199926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.
    Shasha B; Lang R; Rubinstein E
    Antimicrob Agents Chemother; 1992 May; 36(5):973-6. PubMed ID: 1510422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline: its potential for treatment of brucellosis.
    Dizbay M; Kilic S; Hizel K; Arman D
    Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of doxycycline, streptomycin, cotrimoxazole and rifamycin on the functions of normal human neutrophils against Brucella melitensis.
    Orduña A; Orduña C; Zarzosa P; Bratos MA; Ortiz de Lejarazu R; Rodríguez-Torres A
    J Chemother; 1989 Jul; 1(4 Suppl):429-31. PubMed ID: 16312472
    [No Abstract]   [Full Text] [Related]  

  • 10. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis].
    Alişkan H; Turunç T; Demiroğlu YZ; Colakoğlu S; Arslan H
    Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.
    Lang R; Shasha B; Rubinstein E
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of BAY y 3118, a novel 4-quinolone, against Brucella melitensis.
    García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo MJ
    J Chemother; 1994 Apr; 6(2):102-6. PubMed ID: 8077983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey.
    Yamazhan T; Aydemir S; Tünger A; Serter D; Gökengin D
    Med Princ Pract; 2005; 14(6):413-6. PubMed ID: 16220015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
    Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
    Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.
    Orhan G; Bayram A; Zer Y; Balci I
    J Clin Microbiol; 2005 Jan; 43(1):140-3. PubMed ID: 15634962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotypes and antimicrobial susceptibilities of Brucella isolates.
    Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
    Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of environmental conditions (pH and serum) on the in vitro potency of azithromycin against Brucella melitensis.
    Domingo S; Gastearena I; Diaz R; Gamazo C
    J Chemother; 1995 Nov; 7 Suppl 4():29-31. PubMed ID: 8904096
    [No Abstract]   [Full Text] [Related]  

  • 18. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
    Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline.
    Seleem MN; Jain N; Pothayee N; Ranjan A; Riffle JS; Sriranganathan N
    FEMS Microbiol Lett; 2009 May; 294(1):24-31. PubMed ID: 19493005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.
    Akova M; Uzun O; Akalin HE; Hayran M; Unal S; Gür D
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1831-4. PubMed ID: 8239591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.